Varda Space Industries
Varda Raises $251M Series D for Space-Based Pharmaceutical Processing
Varda Space Industries announced $251M in Series D financing on September 30, 2026. Varda Space Industries raised a $251 million Series D led by Lux Capital and Natural Capital to scale space-based pharmaceutical processing.
Round details
The financing includes backing from Lux Capital, Natural Capital, Founders Fund, Khosla Ventures, Caffeinated Capital, General Catalyst, 8090 Industries, Giant Step. The company did not publish a valuation with the announcement.
- Round: Series D
- Capital announced: $251M
- Total funding reported: $598M
- Headquarters: El Segundo, CA
How the company plans to use the capital
Varda said the round gives it the resources to increase its cadence, deepen its pharmaceutical partnerships, and get closer to delivering the first medicine made in space.
Why this matters for GTM teams
Since its first mission launched in 2023, Varda has completed six successful reentry missions, with more than a dozen further launches and reentries planned through 2028, according to the announcement.
Fresh capital is often an operational signal rather than a buying signal by itself. Teams should validate the company’s hiring pattern, product launches, geographic expansion, and technology priorities before choosing the message and timing of outreach.
Source and methodology
This report is based on the company’s announcement and records the disclosed amount, round, investors, location, and stated use of funds. SalesTools Research does not estimate undisclosed valuation or revenue figures.
Primary source: Varda Series D announcement.
Company Info
Investors (8)
Share
Related Reports
Infisical Raises $40M Series B for AI Agent Security Infrastructure
Infisical raised a $40 million Series B at a $600 million valuation, led by Elad Gil, to expand security infrastructure for AI agents.
Vera Health Raises $28.5M Series A for Clinical AI Search
Vera Health raised a $28.5 million Series A led by Threshold Ventures to further develop its clinical evidence infrastructure and expand into additional healthcare markets.
Omnichat Raises US$10M Series A for Agentic Customer Experience Platform
Omnichat raised a US$10 million Series A led by Openspace Capital to scale its agentic AI platform, deepen R&D on Omni AI Agents and expand globally.
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free